Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development
Non-alcoholic fatty liver disease (NAFLD), the most frequent cause of chronic liver disease worldwide, is associated with a plethora of metabolic comorbidities such as obesity, prediabetes, type 2 diabetes mellitus, hypertension and dyslipidemia but may be present in a significant percentage of non-...
Guardado en:
Autores principales: | Junli Liu, Maria Dalamaga |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74cdc0d1dfbe47d8aa60f441c52a73d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
por: Aleksandr E. Nosov, et al.
Publicado: (2021) -
Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
por: N. V. Mikhaylova, et al.
Publicado: (2019) -
Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways
por: Tahmina Yasmin, et al.
Publicado: (2021) -
Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Paria Zarghamravanbakhsh, et al.
Publicado: (2021) -
Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)